Loading ......
Filter By Product Search for
SLPI
SLPI Full Name
secretory leukocyte peptidase inhibitor
SLPI Introduction
SLPI encodes the secretory leukocyte protease inhibitor, a small cationic protein of about 12 kDa that belongs to the whey acidic protein family and contains two four-disulfide core domains. The gene is located at 20q13.12 and the protein is produced by epithelial cells of the respiratory, gastrointestinal and reproductive tracts, as well as by neutrophils and macrophages. Its two domains have distinct functions: the C-terminal domain inhibits serine proteases, whereas the N-terminal domain carries antimicrobial and immunomodulatory activity that is independent of protease inhibition.
Figure 1. The structure of SLPI.
Protease Inhibition at Mucosal Surfaces
SLPI is one of the principal inhibitors of neutrophil elastase, cathepsin G and proteinase 3 in the lung, where it protects elastic fibres and epithelial integrity from the collateral damage of inflammation. Its concentration in airway secretions rises in response to bacterial lipopolysaccharide and to neutrophil influx, and deficiency has been linked to exaggerated proteolytic injury in chronic obstructive pulmonary disease and in cystic fibrosis. The protein also inhibits mast cell chymase and pancreatic enzymes, and its antiprotease activity is enhanced by binding to heparin and to cell surface glycosaminoglycans.
Innate Immunity, Wound Repair and HIV
The N-terminal domain of SLPI has broad antimicrobial activity against Gram-positive and Gram-negative bacteria, fungi and herpesviruses, and it dampens inflammation by interfering with NF-kB activation and with monocyte responses to lipopolysaccharide. In wound fluid, SLPI promotes fibroblast proliferation and collagen synthesis, which helps explain the delayed healing observed in mice lacking the protein. SLPI is also present in saliva at concentrations that inhibit HIV infection of macrophages, a finding that prompted investigation of the protein as a topical microbicide, and its expression is frequently reduced in oral and cervical carcinomas.
Alternate Names for SLPI
SLPI; secretory leukocyte peptidase inhibitor; ALP; MPI; ALK1; BLPI; HUSI; WAP4; WFDC4; HUSI-I
Loading ......